Brief: Dr Reddy's Announces First-To-Market Launch Of Bosutinib Tablets 400Mg In The United States
13/06/2026 09:12
BRIEF-Dr Reddy's Announces First-To-Market Launch Of Bosutinib Tablets 400Mg In The United States June 13 (Reuters) - Dr Reddy's Laboratories Ltd REDY.NS:
DR REDDY'S - ANNOUNCES THE FIRST-TO-MARKET LAUNCH OF BOSUTINIB TABLETS 400MG IN THE UNITED STATES
Source text: ID:nPLXQ94HLR
Further company coverage: REDY.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dr. Reddy's Laboratories
See all newsDr Reddy's rolls out new generic Ozempic brands to ease Obeda supply hit
Dr Reddy's beats quarterly profit estimate on India market lift (updated)
India's Dr Reddy's beats quarterly profit estimate
Brief: Dr. Reddy's Q2 Consol Net PAT 9.25 Billion Rupees
Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruption